Digital Content 
NEWS #PharmaBuzz
16 Dec 2022
// GLOBENEWSWIRE
https://www.globenewswire.com/news-release/2022/12/16/2575746/0/en/The-CHMP-has-Adopted-a-Negative-Opinion-for-Omburtamab-for-the-Treatment-of-CNS-LM-Metastasis-from-Neuroblastoma-in-Europe.html
02 Dec 2022
// HEALTH ET
https://health.economictimes.indiatimes.com/news/pharma/u-s-fda-declines-to-approve-y-mabss-pediatric-cancer-drug/95930439
01 Dec 2022
// GLOBENEWSWIRE
https://www.globenewswire.com//news-release/2022/12/01/2566388/0/en/Y-mAbs-Announces-Complete-Response-Letter-for-Omburtamab-Biologics-License-Application.html
01 Nov 2022
// Nick Paul Taylor FIERCEBIOTECH
https://www.fiercebiotech.com/biotech/y-mabs-rare-disease-drug-roundly-rejected-fda-adcomm-over-weakness-single-arm-trial
29 Oct 2022
// GLOBENEWSWIRE
https://www.globenewswire.com/news-release/2022/10/28/2544126/0/en/Y-mAbs-Announces-Outcome-of-FDA-Advisory-Committee-Meeting-on-Omburtamab.html
03 Oct 2022
// GLOBENEWSWIRE
https://www.globenewswire.com/news-release/2022/10/03/2526934/0/en/Y-mAbs-Announces-Pivotal-Data-for-Omburtamab.html
Share 